Healthcare Triangle, Inc. (HCTI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20M 40M 60M Q2 '21: 34.4M Q3 '21: 35.1M Q4 '21: 35.3M Q1 '22: 38.4M Q2 '22: 39.9M Q3 '22: 43.8M Q4 '22: 45.9M Q1 '23: 44.7M Q2 '23: 41.6M Q3 '23: 37.4M Q4 '23: 33.2M Q1 '24: 27.5M Q2 '24: 21.9M Q3 '24: 16.6M Q4 '24: 11.7M Q1 '25: 11.3M Q2 '25: 11.9M Q3 '25: 12.9M Q4 '25: 13.9M Q1 '26: 20M Q2 '26: 25.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 800M 1.6B 2.4B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 2.1B Q4 '25: 2.3B Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating Income TTM

-21M -14M -7M 0 7M 14M 21M Q2 '21: 442.5K Q3 '21: -1.5M Q4 '21: -5.4M Q1 '22: -6.6M Q2 '22: -8.5M Q3 '22: -9M Q4 '22: -16.5M Q1 '23: -17.7M Q2 '23: -17.9M Q3 '23: -17.2M Q4 '23: -7.7M Q1 '24: -6.2M Q2 '24: -6M Q3 '24: -5.6M Q4 '24: -4.8M Q1 '25: -4.4M Q2 '25: -4.4M Q3 '25: -5.8M Q4 '25: -9.8M Q1 '26: -12M Q2 '26: -14.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-18M -12M -6M 0 6M 12M 18M Q2 '21: 1.5M Q3 '21: -625.5K Q4 '21: -5.9M Q1 '22: -7.1M Q2 '22: -7.9M Q3 '22: -8.2M Q4 '22: -14.4M Q1 '23: -15.6M Q2 '23: -17M Q3 '23: -16.6M Q4 '23: -8.7M Q1 '24: -7.3M Q2 '24: -7M Q3 '24: -6.3M Q4 '24: -6M Q1 '25: -5.8M Q2 '25: -5.7M Q3 '25: -6.3M Q4 '25: -9.5M Q1 '26: -14M Q2 '26: -17M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 15M 30M 45M Q2 '21: 24.4M Q3 '21: 24.4M Q4 '21: 24.7M Q1 '22: 27.1M Q2 '22: 28.9M Q3 '22: 32M Q4 '22: 34.6M Q1 '23: 34.7M Q2 '23: 32.8M Q3 '23: 30.4M Q4 '23: 26.4M Q1 '24: 21.3M Q2 '24: 16.8M Q3 '24: 12.4M Q4 '24: 8.8M Q1 '25: 9.1M Q2 '25: 10.1M Q3 '25: 11.2M Q4 '25: 12M Q1 '26: 16.1M Q2 '26: 20.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q4 '21: -7.1M Q1 '22: -4.7M Q2 '22: -3M Q3 '22: -3.6M Q4 '22: -5.4M Q1 '23: -7.3M Q2 '23: -8.7M Q3 '23: -7.7M Q4 '23: -2.2M Q1 '24: -598K Q2 '24: -386K Q3 '24: 329K Q4 '24: -1.1M Q1 '25: -6.6M Q2 '25: -8.3M Q3 '25: -10.5M Q4 '25: -16.5M Q1 '26: -17.8M Q2 '26: -16M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q4 '23: -2.2M Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q3 '20: 27.9M Q1 '21: 29.3M Q2 '21: 29.6M Q3 '21: 28.8M Q1 '22: 35.5M Q2 '22: 35.5M Q3 '22: 36M Q1 '23: 4.2M Q2 '23: 4.3M Q3 '23: 4.3M Q1 '24: 4.5M Q2 '24: 21.4K Q3 '24: 22.8K Q1 '25: 659 Q2 '25: 39.1K Q3 '25: 4.4M Q1 '26: 930.7K Q2 '26: 2.8M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18000.00 -12000.00 -6000.00 0.00 6000.00 12000.00 18000.00 Q2 '21: 0.05 Q3 '21: -0.02 Q4 '21: -0.20 Q1 '22: -0.23 Q2 '22: -0.25 Q4 '23: -2.09 Q1 '24: -1.72 Q2 '24: -72.02 Q3 '24: -126.35 Q4 '24: -16811.12 Q1 '26: -192.31 Q2 '26: -158.86 Q3 '21 Q1 '22 Q4 '23 Q2 '24 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.